von Jerry Easo ; Marcin Szczechowicz ; Philipp Hölzl ; Michael Horst ; Harald Christian Eichstaedt ; Konstantin Zhigalov ; Ahmed Mashhour ; Alexander Weymann ; Otto E. Dapunt
von Konstantin Zhigalov ; Ahmed Mashhour ; Marcin Szczechowicz ; Sabreen Mkalaluh ; Aleksey Baranov ; Jerry Easo ; Steffen Altmann ; Harald Christian Eichstaedt ; Alexander Weymann
von Konstantin Zhigalov ; Marcin Szczechowicz ; Ahmed Mashhour ; Sabreen Mkalaluh ; Dmitrii Safonov ; Soslan Enginoev ; Jerry Easo ; Jürgen Ennker ; Harald Christian Eichstaedt ; Alexander Weymann
von Konstantin Zhigalov ; Marcin Szczechowicz ; Ahmed Mashhour ; Sabreen Mkalaluh ; Maxim Isaev ; Bakitbek Kadyraliev ; Jerry Easo ; Jürgen Ennker ; Harald Christian Eichstaedt ; Alexander Weymann
Published online: 09 August 2018 ; Gesehen am 14.04.2020
cardiac metastases; palliative therapy; surgery
Background Cardiac metastases are more common than primary malignant tumors of the heart and are usually treated surgically as a palliative approach. In this study, we reviewed our experience with the surgical treatment of patients with cardiac metastases of various types of malignant tumors. - - Methods Between 2003 and 2016, 10 patients underwent surgery for cardiac metastases at our institution. - - Results The mean age was 53.5 ± 19 years. Female patients made up 60% (n = 6) of the collective. The cohort included cardiac metastases of diverse origins (peripheral sarcomas, melanoma, rectal carcinoma, and hepatocellular carcinoma). The left side of the heart was more frequently affected (n = 7). In only six patients, the primary malignancy was known at the time of cardiac surgery. The interval between the first diagnosis of the primary tumor and cardiac metastases ranged from simultaneous diagnosis to up to 19 years. At the time of the diagnosis of the cardiac metastases, seven patients already had multiple metastases: all seven patients had pulmonary metastases, and three of them additionally had hepatic, cerebral, or osseous metastases. Only four patients were symptomatic (atrial fibrillation, pericardial effusion, tachycardia with chest pain, dyspnea). There was no in-hospital death. The postoperative course was uneventful overall. The one- and two-year survival rates were similar, that is, 76%. The median follow-up time was 5.4 years. - - Conclusions Surgical intervention for treating cardiac metastases is associated with uneventful clinical outcome and acceptable survival in this critically ill population. Control of the primary malignancy, and maybe other metastases, determines the survival.
The thoracic and cardiovascular surgeon Stuttgart : Thieme, 1953 67(2019), 8, Seite 659-664 Online-Ressource
von Konstantin Zhigalov ; Marcin Szczechowicz ; Ahmed Mashhour ; Bakitbek K. Kadyraliev ; Sabreen Mkalaluh ; Jerry Easo ; Jürgen Ennker ; Harald Christian Eichstaedt ; Alexander Weymann
von Jerry Easo ; Alexander Weymann ; Philipp Hölzl ; Michael Horst ; Harald Christian Eichstaedt ; Ahmed Mashhour ; Konstantin Zhigalov ; Marcin Szczechowicz ; Rohit Philip Thomas ; Anton Sabashnikov ; Otto E. Dapunt
Published: December 15, 2017 ; Gesehen am 02.05.2019
Background: Surgery of the pulmonary valve, right ventricular outflow tract, and pulmonary artery falls under the domain of paediatric cardiac surgery. However, 97 adult patients underwent such operations in our institution from 1993 to 2016. Aim: This study aims to analyse preoperative risk factors, intraoperative data, postoperative outcomes, and long-term survival to identify the potential predictors of mortality and high-risk patients. - Methods: We divided our patient cohort into three groups in accordance with surgical indications: 17 patients with pulmonary valve endocarditis (group A), 70 patients with congenital defects involving the pulmonary valve (group B), and 10 patients who underwent pulmonary valve surgery for other indications, such as tumour or other acquired valvular disease (group C). - Results: Gender distribution was comparable in all the three groups, with about 40% of the total number of patients being female. The mean age was 35.9 ± 15.7 years. Sixty (61.9%) patients had a history of cardiac surgery. Various concomitant cardiac surgical procedures were necessary in 49 (50.5%) cases. There were two (11.8%) in-hospital deaths in group A, two (2.9%) in group B, and none in group C. Within the mean follow-up time of 6.6 ±7.2 years, three (17.7%) patients in group A, two (2.9%) in group B, and four (40%) in group C died. - Conclusions: Adult patients with pulmonary valve disease are often previously heart-operated and often need concomitant procedures. The operative risk in patients with pulmonary valve endocarditis is high. Surgery of congenital defects of the pulmonary valve is safe and can be performed with excellent outcomes.
Kardiologia polska Poznań : Termedia Wydawn., 2003 76(2018), 3, Seite 602-610 Online-Ressource
von Rohit Philip Thomas ; Sandeep Sunder Amin ; Osama Eldergash ; Tobias Johannes Kowald ; Sebastian Hendrik Bremer ; Jerry Easo ; Alexander Weymann ; Malte Book ; Marcin Szczechowicz ; Bernhard Schmuck ; Ajay Chavan
von Ahmed Mashhour ; Konstantin Zhigalov ; Marcin Szczechowicz ; Sabreen Mkalaluh ; Jerry Easo ; Harald Christian Eichstaedt ; Dmitry Borodin ; Jürgen Ennker ; Alexander Weymann